← All organizations
University of Stavanger
Academic/HospitalWebsite ↗
Also known as: Dep. of Neurology, Stavanger University Hospital | Helse Stavanger HF | Rogaland sentralt sykehus - Stavanger-Norway | Sentralsjukehuset i Rogaland | Stavanger Health Research | Stavanger University | Stavanger University Hospital, Norway | Stavanger University Hospital, Stavanger, Norway
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2005Last known activity
Sep 15, 2025
Timeline
2000s
- Jan 1, 2005
University of Stavanger— Founded
Drugs by trial phase (81 distinct, 59 trials)
Phase 4 (16 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Arthritis, Juvenile
- Asthma
- Breast Neoplasms
- Coronary Disease
- Dementia
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Fatigue
- Glioblastoma
- Heart Failure
- Hypertension, Pulmonary
- Infarction
- Inflammation
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lewy Body Disease
- Lung Neoplasms
- Major Depressive Disorder
- Mental Disorders
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Myocardial Infarction
- Neonatal Sepsis
- Neoplastic Cells, Circulating
- Neutropenia
- Opioid-Related Disorders
- Pancreatic Neoplasms
- Parkinson Disease
- Pneumonia
- Postoperative Pain
- Postpoliomyelitis Syndrome
- Psychotic Disorders
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency
- Respiratory Sounds
- Respiratory Tract Infections
- Schizophrenia
- Sciatica
- Sclerosis
- Sjogren's Syndrome
- Small Cell Lung Carcinoma
- Still's Disease, Adult-Onset
- Syndrome
- Thrombocytopenia
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07051915CollaboratorPhase 3Sep 15, 2025
- NCT06774261Lead sponsorPhase 1Feb 1, 2025
- NCT06270407CollaboratorPhase 4Oct 31, 2024
- NCT06440629CollaboratorPhase 4Aug 20, 2024
- NCT06362707Lead sponsorPhase 2Aug 1, 2024
- NCT06419946CollaboratorPhase 3May 15, 2024
- NCT06150261OfficialN/ADec 31, 2023
- NCT06150261Lead sponsorN/ADec 31, 2023
- NCT06150261Overall official - principal investigatorN/ADec 31, 2023
- NCT06119789CollaboratorPhase 2Nov 30, 2023
- NCT06084364CollaboratorPhase 4Nov 3, 2023
- NCT06084364Overall official - principal investigatorPhase 4Nov 3, 2023
- NCT06084364OfficialPhase 4Nov 3, 2023
- NCT06020716Lead sponsorPhase 4Aug 16, 2023
- NCT06020716Study chairPhase 4Aug 16, 2023
Details
- Founded
- Stavanger, NO Jan 1, 2005
- Last known activity
- Sep 15, 2025